Artivion, Inc. (AORT)
45.12
-0.36
(-0.79%)
USD |
NYSE |
Dec 12, 16:00
45.17
+0.05
(+0.11%)
After-Hours: 20:00
Artivion Research and Development Expense (Quarterly): 8.078M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pulse Biosciences, Inc. | 11.39M |
| INVO Fertility, Inc. | 0.00 |
| NeuroOne Medical Technologies Corp. | 1.182M |
| Phibro Animal Health Corp. | -- |
| Nutriband, Inc. | 0.4571M |